3.14500 EUR
0.129
3.94%
Last update Dec 16, 6:35 PM CET
Main market
Day range
3.14500
3.25900
Previous close
3.27400
Open
3.19500
Access this stock data via API
Subscribe
Esperion Therapeutics Inc.
3.15
0.13
3.94%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 283.2M 116.3M 75.5M 78.4M
Cost of revenue 58.5M 43.3M 27.0M 14.2M
Gross profit 224.7M 73.1M 48.5M 64.2M
Operating expense
Research & development 39.4M 86.1M 118.9M 106.0M
Selling general and admin 139.0M 142.5M 109.1M 185.0M
Other operating expenses
Operating income 46.4M -155.6M -179.5M -226.7M
Non operating interest income
Income
Expense 50.5M 59.0M 56.8M 46.4M
Other income expense -40.0M 5.3M 2.7M 4.0M
Pretax income -44.1M -209.2M -233.7M -269.1M
Tax provision
Net income -44.1M -209.2M -233.7M -269.1M
Basic EPS -0.3 -2.0 -3.5 -9.3
Diluted EPS -0.3 -2.0 -3.5 -9.3
Basic average shares 159.5M 111.7M 69.1M 30.1M
Diluted average shares 159.5M 111.7M 69.1M 30.1M
EBITDA 53.3M -150.1M -176.3M -222.1M
Net income from continuing op. -44.1M -209.2M -233.7M -269.1M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 9 hours 15 minutes

10:44
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).